V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012343 | 330004684 | null | 88.6 | Palliative (P) | 2018-02-09 | 2018-07-14 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330013060 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012344 | 330004687 | 1.59 | null | Curative (C) | 2017-10-07 | 2017-10-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330013066 | BENDAMUSTINE + RITUXIMAB |
| 330012345 | 330004690 | 1.66 | 76 | Curative (C) | 2018-05-03 | 2018-05-03 | BENDAMUSTINE + RITUXIMAB | null | N | 330013074 | BENDAMUSTINE + RITUXIMAB |
| 330012346 | 330004704 | null | 94 | Palliative (P) | 2016-05-19 | 2016-07-17 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 330013123 | PACLITAXEL |
| 330012347 | 330004710 | null | null | Curative (C) | 2015-03-01 | 2015-09-12 | Carbo F | null | null | 330013142 | CARBO + FLUOROURACIL |
| 330012348 | 330004713 | 1.58 | 54.15 | Palliative (P) | 2015-03-02 | 2015-06-06 | CARBOPLATIN + PACLITAXEL | 02 | N | 330013155 | CARBOPLATIN + PACLITAXEL |
| 330012349 | 330013054 | null | 52 | Curative (C) | 2015-10-12 | 2016-04-09 | VAI (Ifos 3g/m2) | null | null | 330013194 | VAI |
| 330012350 | 330004731 | null | 50.7 | Palliative (P) | 2015-07-29 | 2015-08-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330013234 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012351 | 330004736 | 1 | 63.3 | Neo-adjuvant (N) | null | 2018-03-04 | CARBOPLATIN + ETOPOSIDE | null | null | 330013247 | CARBOPLATIN + ETOPOSIDE |
| 330012352 | 330008581 | 1.51 | 90 | Adjuvant (A) | 2013-02-26 | 2013-06-01 | Cetuximab + Radiotherapy Maint | N | N | 330013250 | CETUXIMAB + RT |
| 330012353 | 330004752 | 1.57 | 99.6 | null | 2016-09-16 | 2016-10-30 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 330013281 | CARBO + FLUOROURACIL |
| 330012354 | 330004760 | null | null | Curative (C) | 2017-06-08 | 2017-06-09 | BENDAMUSTINE + RITUXIMAB | null | null | 330013308 | BENDAMUSTINE + RITUXIMAB |
| 330012355 | 330004765 | 1.62 | 45 | null | 2017-08-05 | 2017-08-05 | CARBO + FLUOROURACIL | null | null | 330013311 | CARBO + FLUOROURACIL |
| 330012356 | 330004782 | 1.79 | 72 | Curative (C) | null | 2018-12-18 | ALL UKALL2011 Maintenance A1 | null | Y | 330013532 | UKALL2011 |
| 330012357 | 330008609 | 1.7 | 48.4 | Curative (C) | 2015-11-25 | 2016-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330013620 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012359 | 330011814 | null | 95 | Palliative (P) | 2017-03-17 | 2017-04-01 | ALL UKALL2011 Maintenance A1 | N | N | 330013738 | UKALL2011 |
| 330012360 | 330004814 | 1.69 | 93.2 | Adjuvant (A) | 2017-11-14 | 2018-03-06 | VAI (Ifos 3g/m2) | N | N | 330013921 | VAI |
| 330012361 | 330004816 | 1.68 | 112 | Curative (C) | null | 2018-10-02 | TEMOZOLOMIDE | N | null | 330013930 | TEMOZOLOMIDE |
| 330012362 | 330008629 | 1.78 | null | Curative (C) | 2017-02-27 | 2017-03-01 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 330013942 | DA |
| 330012363 | 330010677 | 1.24 | 55 | Curative (C) | 2017-09-15 | 2018-02-12 | DA 3+8 | N | N | 330013969 | CISPLATIN + DOXORUBICIN |
| 330012364 | 330004832 | 1.77 | 74 | Palliative (P) | null | 2015-06-20 | Trabectedin | N | null | 330014044 | TRABECTEDIN |
| 330012365 | 330004838 | null | 62.35 | Curative (C) | 2013-06-18 | 2013-07-06 | FLAG + Idarubicin | N | N | 330014135 | FLAG + IDARUBICIN |
| 330012366 | 330010685 | 1.77 | 65 | Palliative (P) | 2014-06-21 | 2014-10-11 | Trabectedin | N | Y | 330014152 | TRABECTEDIN |
| 330012367 | 330004841 | 1.9 | 68 | Curative (C) | 2014-09-07 | 2016-02-03 | EURO-EWING | N | N | 330014163 | EURO-EWING |
| 330012368 | 330004853 | 1.69 | 65 | Curative (C) | 2016-12-10 | 2016-11-29 | Cisplatin + Doxorubicin | N | N | 330014295 | NIVOLUMAB |
| 330012369 | 330004864 | 1.7 | 75.8 | Palliative (P) | 2016-04-24 | 2016-04-24 | GemCarbo Days 1+8 | N | N | 330014435 | GEMCARBO |
| 330012370 | 330008658 | 1.72 | 40 | Radical (R) | 2015-06-04 | 2015-10-11 | FLAG + Idarubicin | 02 | N | 330014444 | FLAG + IDARUBICIN |
| 330012372 | 330004877 | 1.58 | 61 | Palliative (P) | 2013-11-09 | 2013-11-13 | ETOPOSIDE | 2 | N | 330014546 | ETOPOSIDE |
| 330012373 | 330010697 | 1.83 | 8.4 | Neo-adjuvant (N) | 2013-09-01 | 2013-09-08 | CNS Low Grade Glioma Vinblastine | 02 | N | 330014643 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330012374 | 330004889 | 1.6 | 81.8 | Palliative (P) | 2016-02-27 | 2016-02-27 | FLAG + Idarubicin | 02 | N | 330014715 | FLAG + IDARUBICIN |
| 330012375 | 330004894 | 0 | 79 | Palliative (P) | 2014-12-29 | 2014-12-29 | DA 3+8 | 02 | N | 330014753 | CISPLATIN + DOXORUBICIN |
| 330012377 | 330008678 | 1.73 | 59 | Palliative (P) | 2015-04-24 | 2015-07-17 | Methotrexate intrathecal | 02 | null | 330014785 | METHOTREXATE INTRATHECAL |
| 330012379 | 330004910 | 1.7 | 86 | Curative (C) | 2015-02-01 | 2015-03-02 | Azacitidine | N | N | 330014877 | CISPLATIN + DOXORUBICIN |
| 330012380 | 330004914 | 1.72 | 100.7 | Disease modification (D) | 2013-12-19 | 2013-12-20 | Methotrexate intrathecal | N | null | 330014897 | METHOTREXATE INTRATHECAL |
| 330012381 | 330008691 | 1.77 | 137 | null | 2015-05-15 | 2015-05-16 | Azacitidine | 2 | N | 330014928 | VINBLASTINE |
| 330012383 | 330004941 | 1.64 | 108.1 | Palliative (P) | 2014-04-18 | 2014-04-20 | EW EuroEwing 99 : VIDE | N | N | 330015115 | EURO-EWING |
| 330012384 | 330004944 | null | 57.1 | Palliative (P) | 2014-09-11 | 2014-11-02 | Methotrexate intrathecal | null | null | 330015116 | METHOTREXATE INTRATHECAL |
| 330012385 | 330008704 | 1.04 | 15.3 | Curative (C) | 2014-11-24 | 2014-11-24 | FLAG + Idarubicin | Y | N | 330015173 | FLAG + IDARUBICIN |
| 330012386 | 330012476 | 1.7 | 13.9 | Disease modification (D) | 2017-07-10 | 2017-07-21 | ETOPOSIDE | N | N | 330015176 | ETOPOSIDE |
| 330012387 | 330004958 | 1.66 | 67.4 | Palliative (P) | 2016-03-07 | 2016-03-13 | Temozolomide 200mg/m2 | 02 | N | 330015177 | CISPLATIN + DOXORUBICIN |
| 330012388 | 330004962 | null | 72.7 | Palliative (P) | 2014-12-29 | 2014-12-30 | VAC | 02 | N | 330015195 | NIVOLUMAB |
| 330012389 | 330004971 | 1.64 | 14.9 | Neo-adjuvant (N) | 2018-12-02 | 2018-12-02 | Trabectedin | 02 | N | 330015329 | TRABECTEDIN |
| 330012390 | 330013059 | 1.72 | 97 | Palliative (P) | 2015-08-08 | 2015-11-30 | Docetaxel 75mg/m2 (21 day) | 2 | null | 330015334 | DOCETAXEL |
| 330012391 | 330004973 | null | 45.2 | Adjuvant (A) | null | 2018-01-15 | Cisplatin + Doxorubicin | N | N | 330015345 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330012392 | 330008719 | 1.66 | 23 | Palliative (P) | 2013-10-22 | 2013-11-03 | Methotrexate intrathecal | 2 | N | 330015523 | METHOTREXATE INTRATHECAL |
| 330012393 | 330004992 | 0 | 63 | Palliative (P) | 2017-10-20 | 2017-10-20 | VAC | N | N | 330015651 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330012394 | 330008734 | null | 52.2 | Palliative (P) | 2015-06-18 | 2015-06-25 | Azacitidine | 01 | N | 330015848 | DA |
| 330012395 | 330005010 | 1.6 | 37.4 | Curative (C) | 2013-04-13 | 2013-10-06 | Cytarabine High Dose | N | N | 330015927 | CYTARABINE HIGH DOSE |
| 330012396 | 330010739 | 1.75 | 48.6 | Palliative (P) | 2013-03-28 | 2013-12-26 | Liposomal Doxorubicin (Caelyx) | N | N | 330015927 | LIPOSOMAL DOXORUBICIN |
| 330012397 | 330005018 | null | 71 | Palliative (P) | 2013-09-11 | 2013-09-30 | Liposomal Doxorubicin (Caelyx) | 2 | null | 330015971 | LIPOSOMAL DOXORUBICIN |